MX2022003218A - Vacunas para abejas y metodos de uso. - Google Patents

Vacunas para abejas y metodos de uso.

Info

Publication number
MX2022003218A
MX2022003218A MX2022003218A MX2022003218A MX2022003218A MX 2022003218 A MX2022003218 A MX 2022003218A MX 2022003218 A MX2022003218 A MX 2022003218A MX 2022003218 A MX2022003218 A MX 2022003218A MX 2022003218 A MX2022003218 A MX 2022003218A
Authority
MX
Mexico
Prior art keywords
methods
provides compositions
bee
vaccines
infection
Prior art date
Application number
MX2022003218A
Other languages
English (en)
Inventor
Dalial Freitak
Annette Kleiser
Original Assignee
Dalan Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalan Animal Health Inc filed Critical Dalan Animal Health Inc
Publication of MX2022003218A publication Critical patent/MX2022003218A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)

Abstract

La divulgación proporciona composiciones y métodos para tratar y vacunar insectos y poblaciones de insectos de enfermedades bacterianas. La divulgación proporciona además composiciones y métodos para inmunizar profilácticamente a las colmenas de abejas para protegerlas de la infección de la enfermedad de la loque. En los alcances, la divulgación proporciona además composiciones y métodos para inmunizar profilácticamente la colmena de abejas para protegerla de la infección de la loque americana causada por la larva Paenibaccilus.
MX2022003218A 2019-09-18 2020-09-17 Vacunas para abejas y metodos de uso. MX2022003218A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962901988P 2019-09-18 2019-09-18
PCT/US2020/051301 WO2021055625A1 (en) 2019-09-18 2020-09-17 Bee vaccines and methods of use

Publications (1)

Publication Number Publication Date
MX2022003218A true MX2022003218A (es) 2022-07-11

Family

ID=74883486

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003218A MX2022003218A (es) 2019-09-18 2020-09-17 Vacunas para abejas y metodos de uso.

Country Status (9)

Country Link
US (1) US20220354940A1 (es)
EP (1) EP4031169A4 (es)
KR (1) KR20220066296A (es)
CN (1) CN114828880A (es)
AU (1) AU2020351177A1 (es)
CA (1) CA3151793A1 (es)
IL (1) IL291180A (es)
MX (1) MX2022003218A (es)
WO (1) WO2021055625A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4304639A1 (en) * 2021-03-12 2024-01-17 Dalan Animal Health, Inc. Vaccine method and composition for bacterial diseases in invertebrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825839D0 (en) * 1998-11-26 1999-01-20 Univ Cardiff Foulbrood treatments
US10994001B2 (en) * 2015-07-24 2021-05-04 Dalan Animal Health Inc. Edible vaccination against microbial pathogens

Also Published As

Publication number Publication date
CA3151793A1 (en) 2021-03-25
EP4031169A1 (en) 2022-07-27
AU2020351177A1 (en) 2022-03-31
US20220354940A1 (en) 2022-11-10
EP4031169A4 (en) 2023-11-01
CN114828880A (zh) 2022-07-29
IL291180A (en) 2022-05-01
KR20220066296A (ko) 2022-05-24
WO2021055625A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
DOP2010000166A (es) Derivados de aminobenzamida como agentes utiles para el control de parasitos de animales
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
WO2008060591A3 (en) Compositions and methods for inhibiting a honey bee pathogen infection on controlling a hive infestation
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
AR108253A1 (es) Composición de formulación de pesticida microbiano y su método de producción y uso
MX2019006773A (es) Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.
MX2022003218A (es) Vacunas para abejas y metodos de uso.
CL2017001454A1 (es) Métodos para preparar composiciones que contienen alcaloides y usos de las mismas
PH12020552130A1 (en) Vaccination against porcine circoviruses
AR110618A1 (es) Formulado que promueve la polinización dirigida de abejas melíferas hacia cultivos de pera
WO2020055547A3 (en) Methods and compositions for honey bee health
CO2021004965A2 (es) Composición para ácaros y método para criar ácaros
Uieda et al. Should the use the vampiricide paste be abolished in the control of the hematophagous bat, the main transmitter of rabies to humans and herbivores in Latin America?
Deepthi et al. Eye Worm infection in a Cattle-A Case Report
RU2011108858A (ru) Средство для повышения роста и сохранности молодняка
RU2013114157A (ru) Способ повышения воспроизводительной способности норок
RU2010120755A (ru) Вакцина, ассоциированная против парвовирусной, реовирусной, герпесвирусной типа i инфекций и вирусной диареи - болезни слизистых оболочек крупного рогатого скота, инактивированная эмульсионная
Meintjes et al. Host preference of the sheep scab mite, Psoroptes ovis
Meintjies et al. Host preference of the sheep scab mite, Psoroptes ovis
MD80Z (ro) Metodă de profilaxie şi tratament al parazitozelor la bovine
WO2015189711A3 (en) Veterinary composition and method of improving livability of animals, promoting live weight gain in mammals and birds, enhancing the effectiveness of immunization, and preventing and/or treating infectious diseases (variants)
Veneziano et al. Clinical Trial on the efficacy and safety of Fenbendazole oral suspension (Panacur, 10%) on donkeys naturally infected by intestinal Strongylidae.
Hembram et al. Clinical management of sarcoptic mange in rabbits
Ananta Hembram et al. Clinical management of sarcoptic mange in rabbits.
MX2023000097A (es) Adyuvantes de vacunas y metodos de sintetizacion y uso de estos.